- A supported by 56-Crores Social Impact Investment, this multi-year-old program has been anchored by the newly installed Hyundai Center for Cancer Genomics.
Hyundai Motor India Foundation (HMIF), Hyundai Motor India Limited (HMIL) CSR Arm, in partnership with the Indian Institute of Technology Madras (IIT Madras), has launched 'Hyundai Hope for Cancer', which aims to improve children's cancerful care in India. A supported by one 56-crores social impact investment from HMIF, this multi-year-old program has been anchored by the newly installed Hyundai Center for Cancer Genomics.
Located in the main campus of IIT Madras in Chennai, the center will have the facility of India's first community-based cancer tissue biobank. This feature is designed to enable advanced genomic research in pediatric leukemia and lymphoma. By identifying genetic mutations through genomic sequencing, the Center aims to manufacture national childhood cancer genome database and enable more personal treatment protocols. It will also serve as a collaborative hub for physicians, researchers, pharmaceutical experts, and International Cancer Genome Consortium (ICGC) and WHO's International Agency for Research on Cancer (IARC).
Speaking at the event, India's Education Minister, Dharmendra Pradhan said, “Hyundai Hopa National Education Policy for cancer initiatives forward -In 2020, Deep Industry -Academia Partnership, Translational Research, and Talent Carecare and Genomics promoted talent development in the advance areas of healthcare and genomics. Confirms
Also Read: Hyundai Motor India secured Crisil AAA/Stable and A1+ Credit rating
Extensive research:
As part of its mandate, the Hyundai Center for Cancer Genomics aims to collect and sequin 1,600 samples, provides free treatment to 30–50 children, and trains 100 technicians in genomics. HMIF has additionally installed a dedicated 3-crore cancer care funds to ensure that economically disadvantaged families can use timely treatment.
In the next four years, the program will organize 225 awareness and screening camps in Tamil Nadu, Haryana and Maharashtra, target 1.27 lakh persons and manage HPV vaccination to 5,000 girls.
Commenting on the initiative, HMIL managing director, UNOSO Kim said, “Our global direction of” progress to humanity “, Hyundai Motor India is proud to cooperate with IIT Madras on this transformative initiative.
Director of IIT Madras Prof.. V. Kamakoti said, “We are happy to partner with Hyundai Motor India for a project of such national importance. This research center will catalyze success in pediatrics oncology, resulting in diagnosis and targeted treatments.
Get insight into state -of -the -art technology changing upcoming cars, electric vehicles, bikes in India and automotive landscape.
First published date: 04 September 2025, 14:20 pm IST